With the emphasis on preventative healthcare gradually growing, brands have employed novel ingredients and delivery systems to offer a wider range of products for a larger demographic.
In this month's Nutrition Asia series, we speak to TSI Pharmaceuticals' chief strategy officer and director of sales and marketing, Gabriel Perera, who tells us how more Asian parents are investing in bone and joint health supplements for their children.
Perera also elaborates on how traditional ingredients such as glucosamine and chondroitin still have great potential for innovation for different applications and in novel delivery formats, as well as how best to market bone and joint health products to young adults.
In addition, we speak to Vincent Candrawinata, founder of nutraceutical firm Renovatio, who delves into how perceptions surrounding bone and joint health ingredients have changed, and how companies have begun to look at different therapeutic targets when developing products.
At the same time, Candrawinata reveals the latest area of research Renovatio is working on with regards to bone and joint health, and tells us what we can expect in terms of new product development.
Watch the video to find out more.
